版本:
中国

Valeant in talks to sell eye surgical products business - Bbg

June 6 Canadian drugmaker Valeant Pharmaceuticals International Inc is in talks to sell its Bausch & Lomb unit's surgical products business to Germany's Carl Zeiss Meditec AG, Bloomberg reported.

Valeant's eye-surgery assets may be valued at about $2 billion in a sale, Bloomberg reported, citing people familiar with the matter. (bloom.bg/2sckufc)

Valeant and Carl Zeiss were not immediately available for comment. (Reporting by Ahmed Farhatha in Bengaluru; Editing by Maju Samuel)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐